MASSARO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.507
EU - Europa 451
AS - Asia 198
AF - Africa 13
SA - Sud America 10
Totale 2.179
Nazione #
US - Stati Uniti d'America 1.497
IT - Italia 156
SE - Svezia 120
SG - Singapore 73
IN - India 71
CN - Cina 47
FI - Finlandia 44
DE - Germania 25
GB - Regno Unito 20
BG - Bulgaria 11
FR - Francia 11
IE - Irlanda 11
UA - Ucraina 11
RO - Romania 8
TG - Togo 8
BE - Belgio 7
CA - Canada 7
NL - Olanda 7
CH - Svizzera 6
PL - Polonia 5
AR - Argentina 4
HU - Ungheria 4
IL - Israele 3
BR - Brasile 2
CL - Cile 2
RS - Serbia 2
SC - Seychelles 2
AT - Austria 1
AZ - Azerbaigian 1
BZ - Belize 1
CI - Costa d'Avorio 1
CO - Colombia 1
ES - Italia 1
GH - Ghana 1
GL - Groenlandia 1
HK - Hong Kong 1
KZ - Kazakistan 1
MX - Messico 1
PE - Perù 1
SI - Slovenia 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 2.179
Città #
Fairfield 249
Chandler 148
Woodbridge 123
Ashburn 103
Seattle 85
Dearborn 82
Houston 79
Wilmington 79
Cambridge 76
Rome 49
Singapore 45
Princeton 42
Ann Arbor 39
Plano 34
San Paolo di Civitate 31
Lawrence 26
Beijing 22
Helsinki 19
Boston 18
Des Moines 16
Millbury 16
San Diego 14
Dublin 11
Sofia 11
Andover 10
New York 10
Southend 9
Lomé 8
Norwalk 8
Brussels 7
Nanjing 7
Phoenix 7
Los Angeles 6
Mannheim 6
Grafing 5
Kunming 5
Monterotondo 5
Santa Clara 5
Budapest 4
Bühl 4
Federal 4
Fremont 4
Guangzhou 4
Milan 4
Toronto 4
Warsaw 4
Bern 3
Boardman 3
Dallas 3
Jacksonville 3
Paris 3
Tel Aviv 3
Trani 3
Zurich 3
Auburn Hills 2
Belgrade 2
Bremen 2
Centro 2
Chicago 2
Delft 2
Edinburgh 2
Falls Church 2
Genova 2
Hanover 2
Indiana 2
Nanning 2
Pomezia 2
San Mateo 2
Spinea 2
Stockholm 2
Turin 2
Abidjan 1
Ashgabat 1
Baku 1
Barcelona 1
Bari 1
Bogotá 1
Chennai 1
Civitanova Marche 1
Clifton 1
Florence 1
Frankfurt am Main 1
Gallatin 1
Halle 1
Harfleur 1
Hefei 1
Hong Kong 1
Hyderabad 1
Islington 1
Jinan 1
Jönköping 1
Kamampa 1
Lachine 1
Las Vegas 1
Leawood 1
Lima 1
London 1
Mahé 1
Muizenberg 1
Nanchang 1
Totale 1.634
Nome #
Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-phospholipid Syndrome: Two Distinct Mechanisms? 102
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review 91
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study 91
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 85
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models 85
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 85
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 85
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 79
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment 76
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 76
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 75
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 75
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows 73
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 73
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 69
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 68
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 68
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 66
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 62
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio 61
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus Nephritis: Correlation with Histologic Findings. 59
Biological therapies in rheumatic diseases 58
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study 58
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. 57
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus 54
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 52
Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models (PLoS ONE (2018) 13: 12 (e0207926) DOI: 10.1371/journal.pone.0207926) 52
Acne indotta da micofenolato mofetile in pazienti affetti da lupus eritematoso sistemico: uno studio retrospettivo. 52
Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study 47
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 43
STUDIO PROSPETTICO MONOCENTRICO PER LA VALUTAZIONE DELLO STATO DI SALUTE MEDIANTE ‘‘PATIENT ACCEPTABLE SYMPTOM STATE’’ (PASS) IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: CORRELAZIONE GLI INDICI DI ATTIVITÀ DI MALATTIA 42
PREVALENZA DELLO STAFILOCOCCO AUREO NASALE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO 33
CORRELAZIONE FRA CLASSE ISTOLOGICA E INDICE DI ESISTENZA RENALE NEI PAZIENTI CON NEFRITE LUPICA 31
VALUTAZIONE DEL COINVOLGIMENTO DELLE ARTICOLAZIONI METATARSOFALANGEE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: UNO STUDIO ULTRASONOGRAFICO 28
null 22
Mycophenolate mofetil-induced acne in systemic lupus erythematosus. 14
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS 14
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipids antibodies, disease activity and chronic damage 13
Totale 2.274
Categoria #
all - tutte 7.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 0 0 20 51 106 89 58 54 30 18 12
2020/2021148 12 20 7 5 5 7 1 15 39 22 12 3
2021/2022427 6 26 43 24 56 20 13 40 21 33 74 71
2022/2023492 76 112 34 48 50 67 3 36 29 5 28 4
2023/2024188 16 27 7 9 12 21 5 23 1 21 20 26
2024/202569 12 22 28 7 0 0 0 0 0 0 0 0
Totale 2.274